Enzo Biochem Inc (ENZ) - Total Liabilities
Based on the latest financial reports, Enzo Biochem Inc (ENZ) has total liabilities worth $20.12 Million USD as of April 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Enzo Biochem Inc - Total Liabilities Trend (1986–2024)
This chart illustrates how Enzo Biochem Inc's total liabilities have evolved over time, based on quarterly financial data. See ENZ net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Enzo Biochem Inc Competitors by Total Liabilities
The table below lists competitors of Enzo Biochem Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Y&G Corp Bhd
KLSE:7003
|
Malaysia | RM92.53 Million |
|
3R Games SA
WAR:3RG
|
Poland | zł938.00K |
|
ADX Energy Ltd
AU:ADX
|
Australia | AU$28.98 Million |
|
Genenta Science SpA ADR
NASDAQ:GNTA
|
USA | $10.05 Million |
|
Indbank Merchant Banking Services Limited
NSE:INDBANK
|
India | Rs243.98 Million |
|
Bioleaders Corporation
KQ:142760
|
Korea | ₩12.04 Billion |
|
Royal Prima PT
JK:PRIM
|
Indonesia | Rp111.14 Billion |
Liability Composition Analysis (1986–2024)
This chart breaks down Enzo Biochem Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Enzo Biochem Inc market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.84 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.46 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.32 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Enzo Biochem Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Enzo Biochem Inc (1986–2024)
The table below shows the annual total liabilities of Enzo Biochem Inc from 1986 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-07-31 | $29.65 Million | -31.71% |
| 2023-07-31 | $43.42 Million | +4.89% |
| 2022-07-31 | $41.40 Million | -8.23% |
| 2021-07-31 | $45.10 Million | -16.71% |
| 2020-07-31 | $54.16 Million | +162.75% |
| 2019-07-31 | $20.61 Million | +0.36% |
| 2018-07-31 | $20.54 Million | +9.29% |
| 2017-07-31 | $18.79 Million | -15.60% |
| 2016-07-31 | $22.27 Million | -13.65% |
| 2015-07-31 | $25.79 Million | -6.09% |
| 2014-07-31 | $27.46 Million | +10.61% |
| 2013-07-31 | $24.83 Million | +23.99% |
| 2012-07-31 | $20.02 Million | -3.55% |
| 2011-07-31 | $20.76 Million | +13.88% |
| 2010-07-31 | $18.23 Million | +11.51% |
| 2009-07-31 | $16.35 Million | +0.70% |
| 2008-07-31 | $16.23 Million | -5.11% |
| 2007-07-31 | $17.11 Million | +188.16% |
| 2006-07-31 | $5.94 Million | -27.59% |
| 2005-07-31 | $8.20 Million | +32.92% |
| 2004-07-31 | $6.17 Million | -5.07% |
| 2003-07-31 | $6.50 Million | +42.55% |
| 2002-07-31 | $4.56 Million | -15.81% |
| 2001-07-31 | $5.41 Million | +5.97% |
| 2000-07-31 | $5.11 Million | +54.82% |
| 1999-07-31 | $3.30 Million | -2.94% |
| 1998-07-31 | $3.40 Million | 0.00% |
| 1997-07-31 | $3.40 Million | -54.67% |
| 1996-07-31 | $7.50 Million | -34.21% |
| 1995-07-31 | $11.40 Million | -17.39% |
| 1994-07-31 | $13.80 Million | -9.80% |
| 1993-07-31 | $15.30 Million | -8.93% |
| 1992-07-31 | $16.80 Million | -65.15% |
| 1991-07-31 | $48.20 Million | -10.41% |
| 1990-07-31 | $53.80 Million | -9.58% |
| 1989-07-31 | $59.50 Million | +17.59% |
| 1988-07-31 | $50.60 Million | -2.69% |
| 1987-07-31 | $52.00 Million | +2.56% |
| 1986-07-31 | $50.70 Million | -- |
About Enzo Biochem Inc
Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development pro… Read more